Nav: Home

Measuring the tension of a cell with a molecule

August 27, 2018

The volume of cells can vary dramatically. Similarly to an inflating balloon, the volume increase of growing cells pushes on the plasma membrane - the lipid envelop that surrounds the cell. This "turgor" pressure increases the tension of the membrane, which, if left uncorrected, will ultimately cause the cell to burst. To prevent this from happening, cells have evolved mechanisms to monitor the tension of their plasma membrane. When tension is too high, cells respond by increasing the amount of lipid in the membrane. Conversely, when tension is too low, cells remove lipid from the membrane to "tighten" it. How cells manage to sense tension and trigger the appropriate biological response has remained a mystery. It has been difficult to solve due to a lack of tools to study membrane tension within living cells. To tackle this problem, researchers from the University of Geneva (UNIGE) and the National Centre for Competence in Research Chemical Biology (NCCR) have joined forces to create a fluorescent molecule to measure the tension of the plasma membrane of live cells. Using this new tool, they were then able to discover how cells adapt their surface to their volume. A premiere. These results, published in Nature Chemistry and Nature Cell Biology, pave the way for many applications, including in the detection of cancer cells that typically display aberrantly high membrane tension.

When the volume of a cell increases, the tension exerted on its membrane increases, causing activation of TORC2 - a complex of proteins that creates warning signals within the cell. "The cell membrane consists of lipids organized into a semi-permeable bilayer," explains Aurélien Roux, professor in the Department of Biochemistry of the Faculty of Sciences of UNIGE and member of the NCCR. "This surface is fluid, allowing great adaptability of the membrane to changes in the shape and the volume of the cell. Like any surface, it can be stretched and the space between lipids then increases. When this space becomes too big and the membrane may break, a protein, named Slm1, activates TORC2 to produce signals that push the cell to produce new lipids and in turn reduce the tension of the cell membrane." But how can we measure the tension needed to trigger this process?

A fluorescent molecule as a probe of membrane tension

To evaluate the tension of the cell membrane, it is necessary to be able to measure the space between the lipids which constitute this membrane. Stefan Matile, professor in the Department of Organic Chemistry of the Faculty of Sciences of UNIGE and member of the NCCR, has created a "probe molecule", called FliptR (Fluorescent Lipid Tension Reporter), which integrates spontaneously between the lipids of the plasma membrane. "We have developed a fluorescent molecule with two small "fins" that define a certain angle between them, he explains, enthusiastically. This angle varies according to the pressure exerted on FliptR, which changes its fluorescence." Taking advantage of this difference in the fluorescence properties of the molecule, the group of Professor Roux was able to measure the space between the lipids and therefore the tension of a membrane.

With the creation of FliptR, researchers have a valuable new tool for measuring the tension of the plasma membrane in living cells. "We know that cancer cells have higher membrane tension than normal cells. We hope that this fluorescent molecule will one day help to detect them more easily" adds Stefan Matile.

And when it comes to reducing the tension of the cell?

When the tension of the plasma membrane increases, TORC2 is activated and this triggers the production of lipids to lower tension back to basal values. But what happens when the tension of the membrane is too low and has to be increased? "We initially thought that it was happening through the same mechanism running in reverse, but the story turned out to be much more interesting!" says Robbie Loewith, Professor in the Department of Molecular Biology of the UNIGE Faculty of Science and also a member of the NCCR. Indeed, initial research showed that the TORC2 activator Slm1 - involved in sensing too much membrane tension - surprisingly plays no role in the response to too little tension. "On the other hand, we observed that a particular lipid present in the plasma membrane, called PIP2, is the sensor for too little membrane tension."

When membrane tension decreases, PIP2, previously mixed with other lipids, self-segregates to form PIP2 "islands" in a sea of remaining lipids in the membrane, in a process not unlike the spontaneous separation (rising) of cream in fresh milk. As one of the proteins of TORC2 binds PIP2, TORC2 also redistributes to these PIP2 islets. Once engulfed by these islets, TORC2 becomes inactivated. "The lipids of the cell membrane are naturally degraded, and TORC2 activity is necessary to replace them" Robbie Loewith explains. But when TORC2 is inhibited within the PIP2 islets, the degraded lipids are no longer replaced, resulting in an increase in the tension of the plasma membrane. If this recalibration process is blocked, cells cannot adjust the tension of their plasma membrane and die.

A chemical measuring tool to help research in biology

Thanks to the tension measurement technique developed by Stefan Matile and Aurélien Roux, the teams of Professors Roux and Loewith could carry out their experiments on model cells - yeasts - and measure the tension variations of the plasma membrane. "Membrane tension is a very important parameter to control in all cellular processes in which membranes are involved, such as motility, endocytosis (the process through which the cell feeds itself), or cell division, and especially in the case of cancer development", summarize the three researchers. The scientists are now focusing on checking whether the mechanism observed in yeast is the same in human cells, with the long-term idea to develop drugs capable of regulating TORC2, or even of preventing the development of certain cancers.
-end-


Université de Genève

Related Cancer Cells Articles:

New liver cancer research targets non-cancer cells to blunt tumor growth
'Senotherapy,' a treatment that uses small molecule drugs to target ''senescent'' cells, or those cells that no longer undergo cell division, blunts liver tumor progression in animal models according to new research from a team led by Celeste Simon, PhD, a professor of Cell and Developmental Biology in the Perelman School of Medicine at the University of Pennsylvania and scientific director of the Abramson Family Cancer Research Institute.
Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.
Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.
First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.
Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.
Plant-derived SVC112 hits cancer stem cells, leaves healthy cells alone
Study shows Colorado drug SVC112 stops production of proteins that cancer stem cells need to survive and grow.
Changes in the metabolism of normal cells promotes the metastasis of ovarian cancer cells
A systematic examination of the tumor and the tissue surrounding it -- particularly normal cells in that tissue, called fibroblasts -- has revealed a new treatment target that could potentially prevent the rapid dissemination and poor prognosis associated with high-grade serous carcinoma (HGSC), a tumor type that primarily originates in the fallopian tubes or ovaries and spreads throughout the abdominal cavity.
The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.
White blood cells related to allergies may also be harnessed to destroy cancer cells
A new Tel Aviv University study finds that white blood cells which are responsible for chronic asthma and modern allergies may be used to eliminate malignant colon cancer cells.
Conversion of breast cancer cells into fat cells impedes the formation of metastases
An innovative combination therapy can force malignant breast cancer cells to turn into fat cells.
More Cancer Cells News and Cancer Cells Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.